SS Innovations International (SSII) Net Income towards Common Stockholders (2016 - 2026)

SS Innovations International (SSII) reported Net Income towards Common Stockholders of -$3.6 million for Q1 2026, up 20.18% on a YoY basis from -$3.0 million in Q1 2025, and down 165.34% sequentially from $5.5 million in Q4 2025.

SS Innovations International (SSII) Net Income towards Common Stockholders (2016 - 2026) Analysis & Trends

SS Innovations International (SSII) has 11 years of Net Income towards Common Stockholders data on file, last reported at -$3.6 million in Q1 2026.

  • For the quarter ending Q1 2026, Net Income towards Common Stockholders rose 20.18% year-over-year to -$3.6 million; the trailing twelve-month figure through Mar 2026 stood at -$2.1 million (down 224.31% YoY), and the FY2025 full-year result was -$8.2 million, down 1052.11% from the prior year.
  • Net Income towards Common Stockholders retreated to -$3.6 million in Q1 2026, from $5.5 million in the prior quarter.
  • In the past five years, Net Income towards Common Stockholders ranged from a high of $12.9 million in Q4 2024 to a low of -$16.9 million in Q4 2023.
  • A 5-year average of -$1.8 million and a median of -$1.9 million in 2023 frame the typical range for Net Income towards Common Stockholders.
  • Across the five-year window, Net Income towards Common Stockholders tumbled 3620.87% in 2023 and soared 176.42% in 2024, its largest moves.
  • Tracing SSII's Net Income towards Common Stockholders over 5 years: stood at -$998076.0 in 2022, then plunged by 1591.37% to -$16.9 million in 2023, then soared by 176.42% to $12.9 million in 2024, then tumbled by 57.5% to $5.5 million in 2025, then slumped by 165.34% to -$3.6 million in 2026.
  • Business Quant data shows SSII's Net Income towards Common Stockholders at -$3.6 million in Q1 2026, $5.5 million in Q4 2025, and -$3.7 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn 1.08 Bn
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn 745.00 Mn
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn 1.26 Bn
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn 1.34 Bn
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn -
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn 199.50 Mn
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn 411.00 Mn
8 Smith & Nephew 26.99 Bn 26.41 Bn - -
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn 176.78 Mn
10 SS Innovations International 776.19 Mn 752.58 Mn 5.33 Mn -3.58 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -3.58 Mn
Dec 31, 2025 5.48 Mn
Sep 30, 2025 -3.72 Mn
Jun 30, 2025 -256,691.00
Mar 31, 2025 -4.49 Mn
Dec 31, 2024 12.90 Mn
Sep 30, 2024 -6.12 Mn
Jun 30, 2024 -2.93 Mn
Mar 31, 2024 -2.80 Mn
Dec 31, 2023 -16.88 Mn
Sep 30, 2023 -1.22 Mn
Jun 30, 2023 -1.85 Mn
Mar 31, 2023 -2.99 Mn
Dec 31, 2022 -998,076.00
Sep 30, 2022 -456,494.00
Jun 30, 2022 -788,423.00
Mar 31, 2022 -80,421.00
Dec 31, 2021 -352,956.00
Sep 30, 2021 -418,209.00
Jun 30, 2021 -412,314.00